131
Breast carcinoma tissue array, 145 cases, 1 core/case. Clinical stage 0, I, II, III. With survival data. Replacing HBre-Duc150Sur-02 (141 same cases)
(No reviews yet)
Write a Review
- SKU:
- 131-HBreD145Su02-GEN
- Availability:
- IN STOCK
Description
Breast carcinoma tissue array, 145 cases, 1 core/case. Clinical stage 0, I, II, III. With survival data. Replacing HBre-Duc150Sur-02 (141 same cases)
Related Products
Breast tissue array, normal adjacent tissue of HBre-Duc170Sur-01, 90 cases. 1 core/case, with survival information
131
$2,142.00
Breast tissue array, normal adjacent tissue of HBre-Duc170Sur-01, 90 cases. 1 core/case, with survival information
131-HBre-Duc090Sur-01-GEN
Breast carcinoma, 140 cases. 1 core/case with survival data
131
$5,481.00
Breast carcinoma, 140 cases. 1 core/case with survival data
131-HBre-Duc140Sur-02-GEN
Renal pelvis carcinoma and ureter carcinoma tissue array, 120 cases, 1 core/case, with survival data
131
$3,262.00
Renal pelvis carcinoma and ureter carcinoma tissue array, 120 cases, 1 core/case, with survival data
131-HRaU-Uro120Sur-01-GEN
Lung cancer tissue array with matched metastatic carcinoma and cancer adjacent tissue , including TNM, clinical stage, pathology grade and survival data, 30 cases/95 cores, replacing LC952
131
$4,735.50
Lung cancer tissue array with matched metastatic carcinoma and cancer adjacent tissue , including TNM, clinical stage, pathology grade and survival data, 30 cases/95 cores, replacing LC952
131-LC953-GEN
Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage, pathology grade and survival data, 32 cases/95 cores,replacing KD951
131
$4,735.50
Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage, pathology grade and survival data, 32 cases/95 cores,replacing KD951
131-KD951a-GEN